Aplastic Anemia Market is Driven by Innovative Treatments
The Aplastic Anemia Market encompasses a range of therapeutic products designed to address bone marrow failure through immunosuppressive therapies, hematopoietic stem cell transplantation, blood and platelet transfusions, and emerging gene and cell therapies. Immunosuppressive agents, such as antithymocyte globulin and cyclosporine, form the backbone of treatment by inhibiting immune-mediated...
0 Commenti 0 condivisioni 60 Views 0 Anteprima